Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Different-dose botulinum toxin A for lower-limb spasticity in infants and young children with cerebral palsy
ChiCTR-IPR-15006318Phase 4Completed
- Sponsor
- The Third Affiliated Hospital of Zhengzhou University
- Start
- May 2015
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of botulinum toxin type A in cerebral palsy (CP) (6 arms), sponsored by The Third Affiliated Hospital of Zhengzhou University. Primary endpoint: Modified Tardieu Scale. Started May 2015; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
cerebral palsy (CP)
Beyond the preview
Go deeper on ChiCTR-IPR-15006318.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-15006318.